Because both components share one reconstitution date in a co-formulated vial, the shorter of the two in-use windows governs the whole preparation rather than each component being managed independently
Its a simple question, but the answer can vary depending on your specific peptide, desired dosage, and personal protocol
Considerations for Long-Term Users If you plan to use BPC-157 beyond a standard 46 week cycle, consider: Taking extended breaks between cycles Using the lowest effective dose Rotating injection sites to avoid local tissue fatigue or inflammation Monitoring subjective markers of progress and potential side effects (energy, GI symptoms, inflammation, blood pressure) Until clinical data becomes available, long-term safety remains uncertain so the guiding principle should be minimal effective use for specific, time-bound recovery goals
Oral BPC-157: For gut healing and systemic recovery
For experiments requiring immediate use of the entire reconstituted solution, sterile water provides an excellent option
